menu
    • menu

    Company profile for Formycon

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Formycon is a world-leading, independent developer of high-quality biosimilars, meaning follow-on products to biopharmaceutical medicines already on the market. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Our company’s activities span the entire range from technical- pharmaceutical development to clinical trials all the way through to preparation and submission of dos...
    Formycon is a world-leading, independent developer of high-quality biosimilars, meaning follow-on products to biopharmaceutical medicines already on the market. Our focus is on treatments in ophthalmology and immunology as well as for other key chronic diseases. Our company’s activities span the entire range from technical- pharmaceutical development to clinical trials all the way through to preparation and submission of dossiers for regulatory approval. We develop biosimilar medicines to meet the high standards of the world’s most stringently regulated markets: the European Union, the United States, Canada, Japan and Australia.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    FormyconGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Formycon AG Fraunhoferstraße 15 82152 Martinsried/Planegg
    Telephone
    Telephone
    +49 89 864667 100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.formycon.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/formycon
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/formycon

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Formycon AG Research by First Berlin Equity Research
    Formycon AG Research by First Berlin Equity Research

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/original-research-formycon-ag-von-first-berlin-equity-research-gmbh

    PHARMAWEB
    17 Sep 2025
    Share Share
    Horus Pharma Partners with Formycon for Eylea Biosimilar
    Horus Pharma Partners with Formycon for Eylea Biosimilar

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/horus-pharma-becomes-additional-commercialization-partner-for-formycons-eylea-biosimilar-fyb203-in

    PHARMAWEB
    17 Sep 2025
    Share Share
    Formycon Affirms Full-Year Guidance, Raises Working Capital
    Formycon Affirms Full-Year Guidance, Raises Working Capital

    13 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-13/formycon-confirms-full-year-guidance-following-business-development-in-line-with-plan-working-capi

    PHARMAWEB
    13 Aug 2025
    Share Share
    Formycon Presents Ustekinumab Biosimilar FYB202 Data at ECCO
    Formycon Presents Ustekinumab Biosimilar FYB202 Data at ECCO

    20 Feb 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-02-20/formycon-presents-clinical-data-on-ustekinumab-biosimilar-fyb202-at-the-ecco-congress-in-berlin

    PHARMAWEB
    20 Feb 2025
    Share Share
    Lotus Pharma Partners for Eylea® Biosimilar FYB203 in APAC Region
    Lotus Pharma Partners for Eylea® Biosimilar FYB203 in APAC Region

    05 Feb 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-02-05/lotus-pharmaceutical-becomes-strategic-partner-for-the-commercialization-of-formycon-s-eylea-biosim

    PHARMAWEB
    05 Feb 2025
    Share Share
    Teva To Commercialize Formycon’s Eylea Biosimilar In Europe, Israel
    Teva To Commercialize Formycon’s Eylea Biosimilar In Europe, Israel

    13 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/13/3008103/0/en/Teva-Announces-Collaboration-to-Commercialize-Formycon-s-Biosimilar-Candidate-to-Eylea-aflibercept-in-major-parts-of-Europe-and-in-Israel.html

    GLOBENEWSWIRE
    13 Jan 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search